✦ LIBER ✦

Remission of acute myelogenous leukemia in elderly patients with prior refractory dysmyelopoietic anemia

✍ Scribed by Consuelo Murray; Barry Cooper; Lloyd W. Kitchens Jr

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 412 KB
Volume: 52
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19830915)52:6<967::aid-cncr2820520605>3.0.co;2-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transformation of refractory anemia with

Transformation of refractory anemia with excess of blasts into acute myelogenous leukemia with Ph-negative chronic myelogenous leukemia-like characteristics

✍ Dr. Kunihiko Yamauchi; Shigeru Arimori; Tadami Nagao 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

Second complete remission in an elderly

Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine

✍ Amanda F. Cashen; Hollie Devine; John DiPersio 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Association of anemia and cognitive dysf

Association of anemia and cognitive dysfunction in patients with acute myelogenous leukemia and myelodysplastic syndrome

✍ Susan M. Wood; Christina A. Meyers; Stefan Faderl; Hagop M. Kantarjian; Sherry A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB 👁 2 views

Granulocytic sarcoma of the ovary in pat

Granulocytic sarcoma of the ovary in patients with acute myelogenous leukemia

✍ Kou Yamamoto; Dr. Hideki Akiyama; Tamotsu Maruyama; Hisashi Sakamaki; Yasusuke O 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 1 views

A pilot study of interleukin-2 for adult

A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission

✍ Jorge E. Cortes; Hagop M. Kantarjian; Susan O'Brien; Francis Giles; Michael J. K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. Interleukin-2 (IL-2) has immunomodulatory effects, including stimulating the activity of cytotoxic T cells and natural killer cells, and inducing the generation of lymphokine-activated killer cells. The authors investigated whether IL-2 may improve the duration of complete remission

Chromosome changes in a patient achievin

Chromosome changes in a patient achieving complete remission in the acute phase of chronic myelogenous leukemia

✍ Ronald Stern; Julie Sorenson; Doris H. Wurster-Hill; Gibbons G. Cornwell III; O. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views